Pro Pharmaceuticals Group has launched a new initiative to support hospitals with early visibility on emerging medicine supply pressures. This service strengthens planning, improves continuity, and helps clinical teams stay ahead of potential disruptions.

Pro Pharmaceuticals Group will attend CPhI Worldwide 2025 in Frankfurt for the ninth year, focusing on Australian product registrations, comparator (RLD) supplies, and building global partnerships.

Praziquantel 600 mg tablets USP (Endo, USA) pack approved under TGA Section 19A